← Back to Search

Nonsteroidal Anti-inflammatory Drug (NSAID)

Acetaminophen + Naproxen for Postoperative Pain

Phase 3
Recruiting
Research Sponsored by Johnson & Johnson Consumer Inc. (J&JCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Females have a negative urine pregnancy at screening and on the morning of surgery
Weight of 100 pounds or greater and have a body mass index (BMI) of 17.5 to 38.0 (inclusive) at screening
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 48 hours
Awards & highlights

Study Summary

This trial tests if taking a combination of acetaminophen/naproxen sodium can reduce pain over 2 days.

Who is the study for?
This trial is for individuals scheduled for bunion surgery, weighing at least 100 pounds with a BMI of 17.5-38.0, who can follow study procedures and are not on certain medications or have specific health conditions that could affect their safety or the study's integrity. Participants must agree to use contraception and avoid other investigational drugs.Check my eligibility
What is being tested?
The trial tests a fixed combination of acetaminophen/naproxen sodium against a placebo to see if it reduces pain after bunion surgery over 48 hours. Patients will receive multiple doses and their pain levels will be compared to those taking the placebo.See study design
What are the potential side effects?
Potential side effects may include digestive issues like stomach pain or ulcers due to naproxen, liver problems from acetaminophen, allergic reactions, dizziness, headaches, or increased risk of bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not pregnant, as confirmed by tests.
Select...
I weigh at least 100 pounds and my BMI is between 17.5 and 38.
Select...
I agree to only use the study's treatment during the trial.
Select...
My surgery lasted less than 2 hours from start to finish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time-weighted Sum of Pain Intensity Difference Score from 0 to 24 Hours After Dosing (SPID 0-24)
Secondary outcome measures
Percentage of Participants who use Rescue Medication During the First 12 Hours
Time to Confirmed Perceptible Pain Relief (TCPR)
Time to First use of Rescue Medication
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Acetaminophen/Naproxen Sodium Fixed CombinationExperimental Treatment1 Intervention
Participants will receive oral doses of two Acetaminophen/Naproxen Sodium Fixed Combination tablets taken with water. Multiple doses will be administered over a 48-hour period.
Group II: PlaceboPlacebo Group1 Intervention
Participants will receive oral doses of two placebo tablets taken with water. Multiple doses will be administered over a 48-hour period.

Find a Location

Who is running the clinical trial?

Johnson & Johnson Consumer Inc. (J&JCI)Lead Sponsor
52 Previous Clinical Trials
5,374 Total Patients Enrolled
1 Trials studying Pain
440 Patients Enrolled for Pain
Johnson & Johnson Consumer Inc. (J&JCI) Clinical TrialStudy DirectorJohnson & Johnson Consumer Inc. (J&JCI)
2 Previous Clinical Trials
77 Total Patients Enrolled

Media Library

Acetaminophen/Naproxen Sodium Fixed Combination (Nonsteroidal Anti-inflammatory Drug (NSAID)) Clinical Trial Eligibility Overview. Trial Name: NCT05868122 — Phase 3
Pain Research Study Groups: Acetaminophen/Naproxen Sodium Fixed Combination, Placebo
Pain Clinical Trial 2023: Acetaminophen/Naproxen Sodium Fixed Combination Highlights & Side Effects. Trial Name: NCT05868122 — Phase 3
Acetaminophen/Naproxen Sodium Fixed Combination (Nonsteroidal Anti-inflammatory Drug (NSAID)) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868122 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I participate in this research trial?

"To be eligible for the trial, applicants should experience pain and have attained between 16 to 65 years of age. Presently, a total of 120 patients are being sought after."

Answered by AI

Has the Acetaminophen/Naproxen Sodium Fixed Combination been legitimized by the FDA?

"Extensive clinical data has been gathered in support of Acetaminophen/Naproxen Sodium Fixed Combination's safety, and as such it warrants a rating of 3."

Answered by AI

In what locales is this clinical investigation being performed?

"At the moment, 4 medical facilities are recruiting for this trial: First Surgical Hospital in Bellaire, The Heights Hospital in Houston, and Endeavor Clinical Trails in San Antonio being among them."

Answered by AI

Does this trial take individuals aged forty or older as participants?

"This clinical trial only considers participants aged 16 to 65; those younger than sixteen or older than sixty-five should look into the 134 and 663 studies targeting their respective age groups."

Answered by AI

Are there still available vacancies for this research endeavor?

"According to clinicaltrials.gov, this particular medical trial is not presently taking on new patients; the study was initially uploaded on September 1st 2023 and last updated May 11th of the same year. Despite this, there are 878 other trials actively seeking participants."

Answered by AI

Who else is applying?

What site did they apply to?
First Surgical Hospital
The Heights Hospital
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

use to do trials in the past.
PatientReceived no prior treatments
~76 spots leftby Apr 2025